Accro Bioscience
Suzhou
About Accro Bioscience
Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $63.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2025)
- Website: accropeutics.com
- Phone: 0512-62626021
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/accro-bioscience-40206 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.